Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Feb 23, 2022 (Letter of inquiry)

Later deadlines: Mar 23, 2022 (Full proposal)

Grant amount: Up to US $450,000

Fields of work: Drug Abuse

Applicant type: Organizations

Funding uses: Behavioral

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological:

  • Drug abuse treatment interventions, including interventions for patients with comorbidities;
  • Drug abuse treatment and adherence interventions;
  • Drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability;
  • Interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment;
  • Interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and
  • Interventions to treat substance misuse and chronic pain.

Research of interest includes but is not limited to Stage I research.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed March 12, 2019 and last updated March 12, 2019